Karin D. Berg

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

B. Douglas Smith, Mark J. Levis, Miloslav Beran et al. · Blood · 2004 · 629 citations

Medicine, Oncology, Pharmacology +11

Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.

Christine A. Iacobuzio–Donahue, Raheela Ashfaq, Anirban Maitra et al. · PubMed · 2003 · 421 citations

Medicine, Molecular Biology, Oncology +12

Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology

Christine A. Iacobuzio–Donahue, Anirban Maitra, G L Shen-Ong et al. · American Journal Of Pathology · 2002 · 294 citations · Full text

Medicine, Bioinformatics, Oncology +11

Comparison of the Microsatellite Instability Analysis System and the Bethesda Panel for the Determination of Microsatellite Instability in Colorectal Cancers

Kathleen M. Murphy, Shengle Zhang, Tanya Geiger et al. · Journal of Molecular Diagnostics · 2006 · 285 citations · Full text

Medicine, Genetics, Oncology +17

Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay

Kathleen M. Murphy, Mark J. Levis, Michael J. Hafez et al. · Journal of Molecular Diagnostics · 2003 · 216 citations

Life Sciences, Genetics, Molecular Genetics +17